Emerging Companies
The Emerging Companies Section serves the needs of small to medium size BIO member companies most of whom do not yet have major products approved and on the market. This section has its own governing body and fills one-third of the seats on the board of directors. This section operates to bring their opinion to bear on major issues affecting smaller companies, and to construct programs to enhance their development.
Staff Contact: Cartier Esham
John Maraganore, PhD, ECS Chair
Alnylam Pharmaceuticals, Inc
Michael Narachi, Vice Chair
Orexigen Therapeutics, Inc
Jeffrey S. Hatfield, Secretary
Vitae Pharmaceuticals, Inc
Martin Babler
Principia Biopharma
Katrine Bosley
Editas Medicine
Jeff L. Cleland, PhD
Gray Bug, Inc.
Ron Cohen, MD
Acorda Therapeutics, Inc
John F. Crowley, JD, MBA
Amicus Therapeutics, Inc
Michelle Dipp, MD, PhD
OvaScience, Inc.
Douglas A. Doerfler
MaxCyte, Inc
Deborah Dunsire, MD
FORUM Pharmaceuticals Inc
Jean-Francois Formela, MD
Atlas Venture Life Sciences Advisors
Maxine Gowen, PhD
Trevena, Inc.
Peter S. Greenleaf
Sucampo Pharmaceuticals, Inc
Paul J. Hastings
OncoMed Pharmaceuticals, Inc
James Healy, MD, PhD
Sofinnova Ventures
Russell H. Herndon
Hydra Biosciences, Inc
Perry Karsen
Celgene Corporation
Rachel K. King
GlycoMimetics, Inc
Scott Koenig, MD, PhD
MacroGenics, Inc
Jonathan Leff
Deerfield Institute
Nick Leschly
bluebird bio
Bill Lis
Portola Pharmaceuticals, Inc
David Main
Aquinox Pharmaceuticals, Inc.
Joel S. Marcus
Alexandria Real Estate Equities, Inc
Thomas P. Mathers
CoLucid Pharmaceuticals, Inc
John Mendlein, PhD
aTyr Pharma, Inc.
Steven J. Mento, PhD
Conatus Pharmaceuticals, Inc
William J. Newell
Sutro Biopharma, Inc
Christian W. Nolet
Ernst & Young, LLP
John A. Orwin
Relypsa, Inc
Carlos V. Paya, MD, PhD
Immune Design Corporation
Adelene Q. Perkins
Infinity Pharmaceuticals, Inc.
Kristine Peterson
Valeritas, Inc
Mark Pruzanski, MD
Intercept Pharmaceuticals, Inc
Michael G. Raab
Ardelyx Inc.
James Sapirstein, RPh, MBA
Contravir Pharmaceuticals
Nancy Simonian, MD
Syros Pharmaceuticals
Moncef Slaoui, PhD
GSK
David M. Stack
Pacira Pharmaceuticals, Inc.
Gil Van Bokkelen, PhD
Athersys, Inc
Harold E. Van Wart, PhD
CymaBay Therapeutics
Timothy P. Walbert
Horizon Pharma, plc
Neil K. Warma
Opexa Therapeutics
Christoph H. Westphal, MD, PhD
Verastem
Thomas G. Wiggans, MBA
Dermira, Inc.
Bradford A. Zakes, MBA
Cerevast Therapeutics, Inc